Anzeige
Mehr »
Login
Mittwoch, 02.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QJL8 | ISIN: US15687V1098 | Ticker-Symbol: 700
Tradegate
01.04.25
16:05 Uhr
9,000 Euro
-0,144
-1,57 %
Branche
Software
Aktienmarkt
S&P SmallCap 600
1-Jahres-Chart
CERTARA INC Chart 1 Jahr
5-Tage-Chart
CERTARA INC 5-Tage-Chart
RealtimeGeldBriefZeit
9,2729,56022:59
9,3269,52221:59

Aktuelle News zur CERTARA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCertara unveils advanced drug development simulator1
DiCertara Expands the Simcyp Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities70RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has released a new version of the Simcyp Simulator for physiologically-based...
► Artikel lesen
CERTARA Aktie jetzt für 0€ handeln
05.03.Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions80RADNOR, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the appointment of Adrian McKemey, Ph.D. as President...
► Artikel lesen
05.03.Certara, Inc. - 8-K, Current Report-
28.02.KeyBanc maintains Overweight rating on Certara shares with $15 target2
28.02.Certara (NASDAQ:CERT) Earns Market Perform Rating from William Blair1
27.02.TD Cowen sets Certara stock Buy rating, $16 target2
26.02.Certara Reports Fourth Quarter 2024 Financial Results177RADNOR, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the fourth quarter and full...
► Artikel lesen
26.02.Certara, Inc. - 10-K, Annual Report-
26.02.Certara, Inc. - 8-K, Current Report-
15.02.Certara (NASDAQ:CERT) Shares Gap Up - Should You Buy?3
14.02.Certara, Inc. (CERT): Among the Health Information Services Stocks Outpacing the Market in 20256
15.01.Certara estimates higher Q4 revenue15
15.01.Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results191Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Certara...
► Artikel lesen
15.01.Certara, Inc. - 8-K, Current Report-
16.12.24Certara, Inc. - 10-K/A, Annual Report2
13.12.24The Insight Partners: Medical Writing Market Size Indicating $ 9.09 billion by 2031, Featuring Profiles of Cactus Communications, Certara, Covance, Freyr Solutions, InClin Inc1.467The report from The Insight Partners lists several stakeholders-including pharmaceutical and biotech companies, CROs, regulatory authorities, healthcare providers, and academic institutions-along...
► Artikel lesen
06.12.24Cautious Spending By Large Biopharma Client Dragged Certara (CERT) in Q34
02.12.24Certara Showcases 2024 Research Wins With Over 100 Papers Published1
06.11.24Certara Non-GAAP EPS of $0.13 beats by $0.02, revenue of $94.8M misses by $0.77M14
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1